PIMAVANSERIN

PIMAVANSERIN was reported 57532 times

PIMAVANSERIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPUR CELL ANAEMIA 8 0.1194
1 LATENT AUTOIMMUNE DIABETES IN ADULTS 1 0.0058
2 SUPINE HYPERTENSION 1 0.0053
3 NEUROPSYCHIATRIC SYMPTOMS 4 0.0044
4 TRAUMATIC LIVER INJURY 1 0.0043
5 LOW DENSITY LIPOPROTEIN DECREASED 6 0.0042
6 EXCESSIVE SKIN 1 0.0035
7 ANOXIA 1 0.0028
8 DELUSIONAL PERCEPTION 1 0.0024
9 PLEUROTHOTONUS 2 0.0022
10 INTRAOCULAR LENS IMPLANT 1 0.0020
11 INFUSION SITE CELLULITIS 1 0.0019
12 MEDICAL DEVICE SITE INFECTION 1 0.0016
13 RESTING TREMOR 1 0.0015
14 HALLUCINATION, TACTILE 1 0.0015
15 ANAEMIA MACROCYTIC 3 0.0014
16 DRUG-DISEASE INTERACTION 1 0.0014
17 CARCINOID TUMOUR 1 0.0013
18 ARTERIAL INJURY 1 0.0013
19 BASOPHIL COUNT INCREASED 1 0.0013
20 SOLILOQUY 1 0.0012
21 STOMA COMPLICATION 1 0.0010
22 LANGUAGE DISORDER 2 0.0009
23 PROSTATIC OPERATION 1 0.0008
24 MONOCYTE COUNT DECREASED 1 0.0008
25 INFUSION SITE RASH 1 0.0007
26 SPLENIC RUPTURE 1 0.0006
27 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
28 MOTOR DYSFUNCTION 6 0.0006
29 DEVICE ALARM ISSUE 1 0.0006
30 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
31 PSYCHOTIC DISORDER 14 0.0005
32 OCULOGYRIC CRISIS 1 0.0005
33 LIMB MASS 1 0.0005
34 HAEMATOCRIT INCREASED 1 0.0004
35 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
36 PERSECUTORY DELUSION 1 0.0004
37 SEDATION COMPLICATION 1 0.0004
38 MEAN CELL VOLUME INCREASED 1 0.0004
39 HAEMOLYSIS 3 0.0004
40 RED BLOOD CELL COUNT INCREASED 1 0.0004
41 PURPURA 3 0.0003
42 INFUSION SITE REACTION 1 0.0003
43 EMERGENCY CARE 1 0.0003
44 PROSTATITIS 1 0.0003
45 DELUSION 5 0.0003
46 LYMPHOCYTE COUNT INCREASED 1 0.0003
47 BRADYPHRENIA 2 0.0003
48 MONOCYTE COUNT INCREASED 1 0.0003
49 REHABILITATION THERAPY 1 0.0003
50 CEREBRAL ATROPHY 1 0.0003
51 ERECTION INCREASED 1 0.0002
52 HAEMOGLOBIN INCREASED 1 0.0002
53 MENTAL STATUS CHANGES 6 0.0002
54 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
55 NEUTROPHIL COUNT INCREASED 2 0.0002
56 HALLUCINATION, VISUAL 4 0.0002
57 NONSPECIFIC REACTION 1 0.0002
58 PARANOIA 3 0.0002
59 ORTHOSTATIC HYPOTENSION 3 0.0002
60 METABOLIC DISORDER 1 0.0002
61 COGNITIVE DISORDER 8 0.0002
62 HALLUCINATION 12 0.0002
63 SEDATION 4 0.0002
64 ABNORMAL BEHAVIOUR 6 0.0002
65 DROOLING 1 0.0001
66 LYMPHOEDEMA 1 0.0001
67 DEMENTIA 4 0.0001
68 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
69 PELVIC FRACTURE 1 0.0001
70 HALLUCINATION, AUDITORY 2 0.0001
71 BLOOD DISORDER 1 0.0001
72 EMBOLISM 1 0.0001
73 PNEUMONIA ASPIRATION 3 0.0001
74 AGGRESSION 6 0.0001
75 LEUKOCYTOSIS 2 0.0001
76 PNEUMONIA BACTERIAL 1 0.0001
77 HYPOTHERMIA 1 0.0001
78 HIP FRACTURE 3 0.0001
79 ASPIRATION 1 0.0001
80 NEOPLASM 1 0.0001
81 DELIRIUM 3 0.0001
82 MUSCLE RIGIDITY 1 0.0001
83 SCHIZOPHRENIA 1 0.0001
84 AGITATION 6 0.0001
85 BALANCE DISORDER 7 0.0001
86 HYPOPHAGIA 2 0.0001
87 UNRESPONSIVE TO STIMULI 2 0.0001
88 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
89 BRADYCARDIA 4 0.0001
90 JOINT RANGE OF MOTION DECREASED 1 0.0001
91 OEDEMA 4 0.0001
92 RESPIRATORY ARREST 2 0.0001
93 HYPOKINESIA 1 0.0001
94 NEUTROPENIA 9 0.0001
95 THERAPY PARTIAL RESPONDER 1 0.0001
96 SENSORY DISTURBANCE 1 0.0001
97 DRUG INTOLERANCE 6 0.0001
98 CONFUSIONAL STATE 10 0.0001
99 MANIA 1 0.0001
100 DRUG LEVEL INCREASED 1 0.0001
101 NIGHTMARE 2 0.0001
102 DRUG INTERACTION 9 0.0001
103 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
104 LYMPHOCYTE COUNT DECREASED 1 0.0001
105 RESTLESSNESS 2 0.0001
106 LETHARGY 3 0.0001
107 CHOKING 1 0.0001
108 DISORIENTATION 2 0.0001
109 PRESCRIBED UNDERDOSE 1 0.0001
110 FEEDING DISORDER 1 0.0000
111 DYSKINESIA 2 0.0000
112 NEUTROPHIL COUNT DECREASED 2 0.0000
113 RIB FRACTURE 1 0.0000
114 TREATMENT FAILURE 4 0.0000
115 POOR QUALITY SLEEP 1 0.0000
116 DEVICE DISLOCATION 2 0.0000
117 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
118 DEVICE ISSUE 4 0.0000
119 FALL 14 0.0000
120 MENTAL IMPAIRMENT 1 0.0000
121 EXTRAPYRAMIDAL DISORDER 1 0.0000
122 TREATMENT NONCOMPLIANCE 2 0.0000
123 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
124 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
125 DYSSTASIA 1 0.0000
126 DEEP VEIN THROMBOSIS 2 0.0000
127 DEHYDRATION 4 0.0000
128 SOMNOLENCE 6 0.0000
129 ANGER 1 0.0000
130 HAEMATURIA 1 0.0000
131 CEREBRAL HAEMORRHAGE 1 0.0000
132 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
133 C-REACTIVE PROTEIN INCREASED 1 0.0000
134 PANIC ATTACK 1 0.0000
135 UNDERDOSE 2 0.0000
136 SEPSIS 3 0.0000
137 DYSARTHRIA 1 0.0000
138 CONDITION AGGRAVATED 8 0.0000
139 GAIT DISTURBANCE 5 0.0000
140 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
141 DRUG INEFFECTIVE 33 0.0000
142 BLINDNESS 1 0.0000
143 CARDIAC ARREST 2 0.0000
144 URINARY TRACT INFECTION 4 0.0000
145 MENTAL DISORDER 1 0.0000
146 THERAPY NON-RESPONDER 1 0.0000
147 BLOOD CHOLESTEROL INCREASED 1 0.0000
148 ARRHYTHMIA 1 0.0000
149 ANXIETY 6 0.0000
150 DYSPHAGIA 2 0.0000
151 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
152 LEUKOPENIA 1 0.0000
153 HYPOTENSION 4 0.0000
154 DEATH 17 0.0000
155 SPEECH DISORDER 1 0.0000
156 DISTURBANCE IN ATTENTION 1 0.0000
157 RASH PRURITIC 1 0.0000
158 DISEASE PROGRESSION 2 0.0000
159 IRRITABILITY 1 0.0000
160 THERAPEUTIC RESPONSE DECREASED 1 0.0000
161 SUICIDE ATTEMPT 1 0.0000
162 OEDEMA PERIPHERAL 2 0.0000
163 INTENTIONAL OVERDOSE 1 0.0000
164 DEVICE DIFFICULT TO USE 1 0.0000
165 BLOOD PRESSURE DECREASED 1 0.0000
166 MEMORY IMPAIRMENT 2 0.0000
167 SLEEP DISORDER 1 0.0000
168 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
169 MOBILITY DECREASED 1 0.0000
170 INFECTION 2 0.0000
171 OFF LABEL USE 12 0.0000
172 BRONCHITIS 1 0.0000
173 UNEVALUABLE EVENT 1 0.0000
174 PERIPHERAL SWELLING 2 0.0000
175 TREMOR 2 0.0000
176 CEREBROVASCULAR ACCIDENT 2 0.0000
177 PYREXIA 4 0.0000
178 MUSCULOSKELETAL STIFFNESS 1 0.0000
179 SUICIDAL IDEATION 1 0.0000
180 ASTHENIA 4 0.0000
181 PULMONARY EMBOLISM 1 0.0000
182 CONTUSION 1 0.0000
183 ATRIAL FIBRILLATION 1 0.0000
184 SYNCOPE 1 0.0000
185 FLUSHING 1 0.0000
186 PLATELET COUNT DECREASED 1 0.0000
187 CONSTIPATION 2 0.0000
188 INFLUENZA 1 0.0000
189 SEIZURE 1 0.0000
190 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
191 VISUAL IMPAIRMENT 1 0.0000
192 DIZZINESS 4 0.0000
193 LOSS OF CONSCIOUSNESS 1 0.0000
194 INSOMNIA 2 0.0000
195 WEIGHT DECREASED 2 0.0000
196 COUGH 2 0.0000
197 HOSPITALISATION 1 0.0000
198 COVID-19 1 0.0000
199 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
200 NO ADVERSE EVENT 1 0.0000
201 CHEST PAIN 1 0.0000
202 PRODUCT USE ISSUE 1 0.0000
203 NAUSEA 4 0.0000
204 ERYTHEMA 1 0.0000
205 HYPERTENSION 1 0.0000
206 WEIGHT INCREASED 1 0.0000
207 DEPRESSION 1 0.0000
208 INCORRECT DOSE ADMINISTERED 1 0.0000
209 DECREASED APPETITE 1 0.0000
210 PAIN 2 0.0000
211 RASH 1 0.0000
212 MALAISE 1 0.0000
213 FATIGUE 1 0.0000